Press Releases
Lilly Announces Completion of Avid Acquisition and FDA Priority...
Eli Lilly and Company announced that it has completed the acquisition of Avid Radiopharmaceuticals, Inc., a privately held company developing novel molecular imaging compounds intended...
Press Releases
Merck KGaA and sanofi-aventis Sign Agreement to Jointly Investigate...
Merck KGaA announced today that it has signed a worldwide research and development agreement with sanofi-aventis U.S. Inc., under which its division Merck Serono and...
Press Releases
Malaria Vaccine Initiative, Merck and NYU Langone Medical Center...
Development of a vaccine to prevent the malaria parasite from entering the human liver is the goal of a new collaboration announced by global leaders...
Press Releases
New subgroup analysis of the LUX-Lung 1 trial suggests...
New data to be presented show that afatinib (BIBW 2992) leads to a significant four-fold extension (4.4 months vs. 1 month for placebo) in progression-free...
Press Releases
The R and D Leaders Band Together at Discovery...
The Discovery Summit 2011, presented by marcus evans, will be taking place from 21-23 March 2011 in Cannes, France. Confronted by compound challenges the global...
Press Releases
Phase 2 Interim Data Show High Objective Response Rate...
Abbott and Bristol-Myers Squibb Company announced interim results from the Phase 2 portion of a Phase 1b/2 open-label study which showed a high objective response...
Press Releases
FDA Advisory Committee Recommends Approval to Expand Use of...
Allergan, Inc. announced the US FDA Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.